64Indexed trials
Market Rank #40 · Evidence Tier A
Serbia
Neuroscience Intelligence
Serbia neuroscience intelligence: 64 indexed trials, 13 institutions, research score 29.45.
15Recruiting
13Research institutions
29.4Research score
Evidence profile
42Sponsors
17Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 29.4 · Data confidence 100.00 · Evidence 29.4
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
epilepsy9trials
multiple_sclerosis9trials
alzheimers8trials
neuromuscular7trials
parkinsons6trials
schizophrenia6trials
depression4trials
autism3trials
stroke2trials
bipolar_disorder2trials
Leading indexed sponsors
Sumitomo Pharma America, Inc.5trials
Hoffmann-La Roche4trials
Boehringer Ingelheim3trials
Eisai Limited3trials
Genzyme, a Sanofi Company3trials
H. Lundbeck A/S2trials
ACADIA Pharmaceuticals Inc.2trials
Forest Laboratories2trials
Celgene2trials
AbbVie2trials